Related Experiment Video
Updated: Feb 25, 2026

04:36
Author Spotlight: Time and Cost-Effective Fibrinogen-PAGE for Fibrinogenolytic Studies
Published on: April 19, 2024
917
HYPOFIBRINOGENEMIA (A Report of Two Cases).
Harsh Kumar1, P Sivadas2, C Lakshmanan3
1Reader, Dept of Pathology, AFMC, Pune 411 040.
Medical Journal, Armed Forces India
|August 4, 2017
Summary
Hypofibrinogenemia, a rare bleeding disorder, was diagnosed in two siblings with mild bleeding tendencies. This case report highlights the rarity and clinical presentation of this uncommon condition.
Area of Science:
- Hematology
- Genetics
- Pediatrics
Background:
- Hypofibrinogenemia is a rare inherited bleeding disorder characterized by low levels of fibrinogen.
- Fibrinogen is essential for blood clot formation, and its deficiency leads to bleeding diathesis.
- Understanding rare bleeding disorders is crucial for accurate diagnosis and management.
Observation:
- Two siblings presented with a mild bleeding diathesis.
- Clinical investigation confirmed the diagnosis of hypofibrinogenemia in both individuals.
- The familial occurrence suggests a potential genetic basis for the condition.
Findings:
- The siblings were diagnosed with hypofibrinogenemia, an uncommon bleeding disorder.
- The mild bleeding symptoms observed are consistent with this diagnosis.
- The rarity of the condition underscores the importance of thorough diagnostic workups.
Implications:
- This case report contributes to the limited literature on hypofibrinogenemia.
- Early diagnosis and genetic counseling are important for affected families.
- Further research into the genetic underpinnings and treatment options for hypofibrinogenemia is warranted.
Related Concept Videos
Clot Retraction and Fibrinolysis
9.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.5K
Blood Transfusion and Agglutination
15.1K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
15.1K
Disorders of Hemostasis
2.4K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Amyloid Fibrils
12.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Acute Pancreatitis II: Clinical Manifestations and Management
942
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
942

